Pediatric migraine: new diagnostic strategies and treatment options

References

• Stewart WF, Linet MS, Celantano DD et al. Age and sex-specific incidence rates of migraine with and without visual aura. Am. J. Epidemiol. 34, 1111–1120 (1991).
   Google Scholar
• Stewart WF, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA 267, 64–69 (1992).
   PubMed Web of Science ®Google Scholar
• Headache ClassificationCommittee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8, 1–96 (1988).
   Web of Science ®Google Scholar
• Headache ClassificationSubcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalagia 24(Suppl. 1), 24–36 (2004).
   PubMedGoogle Scholar
• Lewis D, Ashwal S, Hershey A et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology. Quality Standards Subcommittee of the Child Neurology Society. Neurology 63, 2214–2215 (2004).
   Google Scholar
• Pakalnis A, Kring D, Paolicchi J. Parental satisfaction with sumatriptan nasal spray in childhood migraine. J. Child Neurol. 18, 772–775 (2003).
   PubMed Web of Science ®Google Scholar
• Winner P. Pediatric headaches: what’s new? Curr. Opin. Neurol. 12, 269–272 (1999).
   PubMedGoogle Scholar
• Holden EW, Deichmann MM, Levy JD. Empirically supported treatments in pediatric psychology: recurrent pediatric headache. J. Pediatric Psychol. 24, 91–109 (1999).
   PubMed Web of Science ®Google Scholar
• Hämäläinen ML, Hoppu K, Velkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled crossover study. Neurology 48, 103–107 (1997).
   PubMed Web of Science ®Google Scholar
• Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia 25, 124–131 (2005).
   PubMed Web of Science ®Google Scholar
• Winner P, Rothner AD, Saper J et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 16, 989–997 (2000).
   Google Scholar
• Ahonen K, Hämäläinen ML, Rantala H Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attaches in children. Neurology 62, 883–887 (2004).
   PubMed Web of Science ®Google Scholar
• Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in the pediatric neurology office practice. Headache 36, 419–422 (1996).
   PubMed Web of Science ®Google Scholar
• Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized, placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults? Neurology 48, 1100–1103 (1997).
   PubMed Web of Science ®Google Scholar
• Winner P, Lewis D, Visser WH et al. Rizatriptan 5mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 42, 49–55 (2002).
   PubMed Web of Science ®Google Scholar
• Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int. J. Clin. Pract. 54, 466–469 (2000).
   PubMed Web of Science ®Google Scholar
• Hershey AD, Winner P, Lewis D, Wasiewski W. Zolmitriptan 5mg nasal spray is effective and well tolerated in the acute treatment of adolescent migraine. Cephalalgia 25, 899 (2005).
   Google Scholar
• Wasiewski WW. Preventive therapy in pediatric migraine. J. Ch. Neurol. 16, 71–78 (2001).
   PubMedGoogle Scholar
• Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 79, 593–597 (1987).
   PubMed Web of Science ®Google Scholar
• Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 44, 230–237 (2004).
   PubMed Web of Science ®Google Scholar
• Hershey AD, Powers SW, Bentti A, deGrauw T. Effectiveness of amitriptyline in the prophylactic management of childhood headache. Headache 40, 539–549 (2000).
   PubMed Web of Science ®Google Scholar
• Leslie L, Newman T, Chesney J, Perrin J. The Food and Drug Administration’s deliberations on anti-depressant use in pediatric patients. Pediatrics 116, 195–204 (2005).
   PubMedGoogle Scholar
• Sorge F, DeSimone R, Marano E et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled crossover study. Cephalalgia 8, 1–6 (1988).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Nobre ME, Moreira P. Low-dose flunarizine for the prevention of migraine in children. Headache 11, 119–121 (2000).
   Google Scholar
• Victor S, Ryan SW. Drugs for preventing migraine headaches in children. Cochrane Database of Syst. Rev. 4, CD002761 (2003).
   Google Scholar
• Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40, 672–676 (2000).
   PubMed Web of Science ®Google Scholar
• Pakalnis A, Greenberg G, Drake ME, Paolicchi J. Pediatric migraine prophylaxis with divalproex. J. Child Neurol. 16, 731–734 (2001).
   PubMedGoogle Scholar
• Hershey AD, Powers SW, Vockel AL et al. Effectiveness of topiramate in the prevention of childhood headache. Headache 42, 810–818 (2003).
   Google Scholar
• Winner P, Pearlman E, Linder S et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45, 1304–1312 (2005).
   PubMed Web of Science ®Google Scholar
• Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache 44, 238–243 (2004).
   PubMed Web of Science ®Google Scholar
• Wang F, VanDen Eeden SK, Ackerson LM et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43, 601–610 (2003).
   PubMed Web of Science ®Google Scholar
• Vogler BK, Pittler MH, Ernst E. Fever few as a preventive treatment for migraine: a systematic review. Cephalalgia 18, 704–708 (1998).
   PubMed Web of Science ®Google Scholar
• Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. Neurology 50, 466–470 (1998).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Göbel H, Einhaupl KM et al. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63, 2240–2244 (2004).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB, Tepper SJ et al. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 63, 843–847 (2004).
   PubMed Web of Science ®Google Scholar